WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

6.11.26

Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
On June 10, 2026, Beren Therapeutics P.B.C., a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, announced it has secured $300 million in combined financing. The financing consists of:
Client Highlights

3.31.26

Wilson Sonsini Advises Crosspoint Capital Partners on TENEX.AI’s $250 Million Series B
On March 31, 2026, TENEX.AI, the AI SOC company transforming security operations, announced a $250 million Series B round of financing led by Crosspoint Capital Partners. Wilson Sonsini Goodrich & Rosati advised Crosspoint on the transaction.

The proceeds from the Series B will accelerate TENEX.AI’s global expansion and significantly scale the human expertise behind its AI-native managed detection and response (MDR) service, expanding the team of defenders and engineers delivering cybersecurity outcomes. The TENEX.AI platform enables AI-driven triage, investigation, hunting, and response to threats in under a minute—with 100 percent alert coverage and human analysts governing every decision and accountable for every outcome.

The Wilson Sonsini team that advised Crosspoint on the financing included:

Corporate
Becki DeGraw
Travis Scheft
Michael Murrietta
Enid Qin
Client Highlights

12.11.25

Wilson Sonsini Advises IVP and Menlo Ventures on Harness’ $240 Million Series E
On December 11, 2025, Harness, an AI software delivery platform company, announced a $240 million Series E financing round, comprised of a $200 million investment led by Goldman Sachs Alternatives and a planned $40 million tender offer with participation from IVP, Menlo Ventures, and Unusual Ventures. Wilson Sonsini Goodrich & Rosati advised IVP and Menlo Ventures on the transaction.
Client Highlights

5.05.25

Wilson Sonsini Advises J.P. Morgan Growth Equity Partners on Rogo’s $50 Million Series B
On April 30, 2025, Rogo, a generative AI start-up focused on financial services, announced the completion of a $50 million Series B financing round led by Thrive Capital, with participation from new investors J.P. Morgan Growth Equity Partners, Tiger Global, and Positive Sum Ventures. Wilson Sonsini Goodrich & Rosati advised J.P. Morgan Growth Equity Partners on the transaction.
Client Highlights

4.25.25

Wilson Sonsini Advises J.P. Morgan Growth Equity Partners on Nourish's $70 Million Series B
On April 23, 2025, Nourish, a leading provider of nutrition counseling, announced a $70 million Series B funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove. Wilson Sonsini advised J.P. Morgan Private Capital’s Growth Equity Partners on the transaction.
Press Releases

11.15.24

Wilson Sonsini Goodrich & Rosati Elects 16 New Partners
Contact:
Kimberly Brooks
Wilson Sonsini
+1 212.453.2881
kbrooks@wsgr.com
Client Highlights

11.13.24

Firm Advises Radical Ventures as Co-Lead Investor on Writer’s $200M Growth Round
On November 12, 2024, Writer, Inc., the full-stack generative AI platform for the enterprise, announced $200 million in Series C venture funding at a $1.9 billion valuation. The round was co-led by Premji Invest, Radical Ventures, and existing investor ICONIQ Growth, with participation from investors including Salesforce Ventures, Adobe Ventures, B Capital, Citi Ventures, IBM Ventures, and Workday Ventures. Existing investors Accenture, Balderton, Insight Partners, and Vanguard also supported the round. The new capital will help cement the company’s leadership in the enterprise generative AI category and fuel its development of enterprise-grade agentic AI. Wilson Sonsini Goodrich & Rosati advised Radical Ventures on the transaction.

Building on its four-year track record of innovation in large language models (LLMs) and enterprise-grade generative AI architecture, Writer will use the new capital to accelerate its development of AI solutions that can plan and execute complex enterprise workflows across systems and teams. The funding will also support a rapid expansion of quick-start AI applications and agents for the most time-intensive workflows in healthcare, retail, and financial services.

The Wilson Sonsini team that advised Radical Ventures on the Series C financing included Becki DeGraw, Adam Shevell, Travis Scheft, William Wiener, Regina McLeod, and Isabel Annino.
Client Highlights

9.19.24

Wilson Sonsini Advises Mangomint on $35 Million Series B
On September 6, 2024, Mangomint, the highest-rated salon and spa software provider, announced a $35 million Series B funding round and a new suite of marketing automation features specifically designed for beauty and wellness businesses. The funding round was led by Altos Ventures, a Silicon Valley-based firm with deep experience in fast-growing vertical software companies, with participation from Jason Lemkin's SaaStr Fund and existing investor OpenView Venture Partners. Wilson Sonsini Goodrich & Rosati advised Mangomint on the transaction.

Since its inception in 2017, Mangomint has focused on improving efficiency and leveraging automation to help independent salon and spa businesses cut costs, save time, and reduce friction in their day-to-day operations. Mangomint's entry into the marketing automation space represents a critical piece of the puzzle in the company's product vision, now enabling small businesses to drive measurable profitability. Mangomint plans to leverage new funding to hire engineering talent to expand on its product vision to drive profitability by building more automation-driven features. The company also plans to hire additional onboarding and support managers to maintain its track record of delivering a top-rated customer experience.

The Wilson Sonsini team that advised Mangomint on the transaction includes Travis Scheft, Becki DeGraw, Manja Sachet, and Rhett Hunt.
Client Highlights

4.30.24

Firm Advises Silk Security on $150 Million Acquisition by Armis
On April 17, 2024, Armis, the asset intelligence cybersecurity company, announced that it has acquired Silk Security, the leading platform for cyber risk prioritization and remediation, for a total of $150 million. Wilson Sonsini Goodrich & Rosati advised Silk Security on the transaction.

Armis will integrate the Silk platform into the Armis Centrix™ AI-based Vulnerability Prioritization and Remediation solution to supercharge its capabilities. The company will now be able to provide security and developer teams with a consolidated view into security findings that encompass all sources of data from locally hosted devices and software to the cloud and beyond, enabling fully managed and automated remediation. The acquisition completes Armis’ strategy of building a comprehensive platform that can see, protect, and manage all assets and devices anywhere in the organization’s digital footprint.

The Wilson Sonsini team that advised Silk Security on the transaction includes:
Client Highlights

1.26.24

Wilson Sonsini Advises Hyperline on $5.2 Million Seed Financing to Build the Web3 Data Lakehouse
On January 23, 2024, Hyperline, a San Francisco, CA-based company creating the first Web3-native data lakehouse, announced that it raised $5.2 million in seed funding. The round was led by Slow Ventures with participation from South Park Commons, Script Capital, Canonical Crypto, Picus Capital, Volt Capital, Mischief, and Maelstrom. Wilson Sonsini Goodrich & Rosati advised Hyperline on the transaction.
Client Highlights

11.29.22

Wilson Sonsini Advises Cajal Neuroscience on $96 Million Series A Financing
On November 29, 2022, Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration, launched with the completion of approximately $96 million in Series A funding. Cajal is uniquely focused on the mechanistic, spatial, and temporal complexity of neurodegeneration, integrating deep expertise in neuroscience, neuroanatomy, and computational biology with state-of-the-art technologies for high-throughput functional validation. The financing was led by The Column Group and Lux Capital, with additional participation from Two Sigma Ventures, Bristol Myers Squibb, Evotec, Alexandria Venture Investments, Dolby Family Ventures, and other investors.
Client Highlights

11.07.22

Wilson Sonsini Advises project44 on $80 Million Funding Round
On November 3, 2022, project44, the leading supply chain visibility platform, announced that it raised an $80 million funding round led by sustainable investment management firm Generation Investment Management and Denmark-based, privately held investment company A.P. Moller Holding. CMA CGM also joined the round, along with previous investors Goldman Sachs Asset Management, TPG, Emergence Capital, Chicago Ventures, Sapphire, 8VC, Sozo Ventures, and Omidyar Technology Ventures. Wilson Sonsini Goodrich & Rosati advised project44 on the transaction.

Today, project44 helps more than 1,200 companies achieve predictability, resilience, and sustainability across their global supply chains. Customers use project44 to ensure on-time delivery of shipments, proactively address supply chain disruptions, and move goods more efficiently. The proceeds from the funding will drive several key initiatives, including measuring and mitigating supply chain emissions globally, across all modes of transportation.

The Wilson Sonsini team that advised project44 on the transaction included:

Corporate
Michael Coke
Travis Scheft
Roy Argand
TJ Tingjie Li
Samuel Silverstein
Henry Yen
  • 1
  • 2
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.